Targetable Oncogenes (EGFR, ALK, ROS1)
1 clinical trials · Condition
◉ Watch Targetable Oncogenes (EGFR, ALK, ROS1)
| Record | Firm | Date |
|---|---|---|
| A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC (NCT02314364) | Massachusetts General Hospital | 2014-12-01 |
Track Targetable Oncogenes (EGFR, ALK, ROS1) automatically
Every clearance here is in the API, with alerts when new ones post.